| The antiretroviral nucleoside analogue Abacavir reduces cell growth and promotes differentiation of human medulloblastoma cells. | |
| | |
MedLine Citation:
|
PMID: 19358275 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Abacavir is one of the most efficacious nucleoside analogues, with a well-characterized inhibitory activity on reverse transcriptase enzymes of retroviral origin, and has been clinically approved for the treatment of AIDS. Recently, Abacavir has been shown to inhibit also the human telomerase activity. Telomerase activity seems to be required in essentially all tumours for the immortalization of a subset of cells, including cancer stem cells. In fact, many cancer cells are dependent on telomerase for their continued replication and therefore telomerase is an attractive target for cancer therapy. Telomerase expression is upregulated in primary primitive neuroectodermal tumours and in the majority of medulloblastomas suggesting that its activation is associated with the development of these diseases. Therefore, we decided to test Abacavir activity on human medulloblastoma cell lines with high telomerase activity. We report that exposure to Abacavir induces a dose-dependent decrease in the proliferation rate of medulloblastoma cells. This is associated with a cell accumulation in the G(2)/M phase of the cell cycle in the Daoy cell line, and with increased cell death in the D283-MED cell line, and is likely to be dependent on the inhibition of telomerase activity. Interestingly, both cell lines showed features of senescence after Abacavir treatment. Moreover, after Abacavir exposure we detected, by immunofluorescence staining, increased protein expression of the glial marker glial fibrillary acidic protein and the neuronal marker synaptophysin in both medulloblastoma cell lines. In conclusion, our results suggest that Abacavir reduces proliferation and induces differentiation of human medulloblastoma cells through the downregulation of telomerase activity. Thus, using Abacavir, alone or in combination with current therapies, might be an effective therapeutic strategy for the treatment of medulloblastoma. |
| | |
Authors:
|
Alessandra Rossi; Giuseppe Russo; Andrew Puca; Raffaele La Montagna; Mariella Caputo; Eliseo Mattioli; Massimo Lopez; Antonio Giordano; Francesca Pentimalli |
Related Documents
:
|
17346255 - Short telomeres in short-lived males: what are the molecular and evolutionary causes? 778505 - Aging in mammalian cell population: a review. 12958145 - Senescence and death of primitive cells and myocytes lead to premature cardiac aging an... 16013445 - Concomitant reduction of matrix metalloproteinase-2 secretion and intracellular reactiv... 12083005 - The intracellular localization of the proteasome. 3963775 - Blink-induced saccadic oscillations. |
Publication Detail:
|
Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: International journal of cancer. Journal international du cancer Volume: 125 ISSN: 1097-0215 ISO Abbreviation: Int. J. Cancer Publication Date: 2009 Jul |
Date Detail:
|
Created Date: 2009-05-04 Completed Date: 2009-05-28 Revised Date: 2010-09-27 |
Medline Journal Info:
|
Nlm Unique ID: 0042124 Medline TA: Int J Cancer Country: United States |
Other Details:
|
Languages: eng Pagination: 235-43 Citation Subset: IM |
Affiliation:
|
Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology, Temple University, Philadelphia PA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Anti-HIV Agents
/
pharmacology* Cell Cycle / drug effects Cell Differentiation / drug effects* Cell Proliferation / drug effects* Cerebellar Neoplasms / drug therapy, pathology* Child Child, Preschool Dideoxynucleosides / pharmacology* Fluorescent Antibody Technique Glial Fibrillary Acidic Protein / metabolism Humans Male Medulloblastoma / drug therapy, pathology* Peritoneal Neoplasms / drug therapy, secondary* RNA, Messenger / genetics, metabolism Reverse Transcriptase Polymerase Chain Reaction Synaptophysin / metabolism Telomerase / genetics, metabolism Tumor Cells, Cultured |
| Grant Support | |
ID/Acronym/Agency:
|
P01 NS036466-07A20002/NS/NINDS NIH HHS; P01 NS036466-080002/NS/NINDS NIH HHS; P01 NS036466-090002/NS/NINDS NIH HHS; P01 NS036466-100002/NS/NINDS NIH HHS; P01 NS036466-110002/NS/NINDS NIH HHS |
| Chemical | |
Reg. No./Substance:
|
0/Anti-HIV Agents; 0/Dideoxynucleosides; 0/Glial Fibrillary Acidic Protein; 0/RNA, Messenger; 0/Synaptophysin; 0/abacavir; EC 2.7.7.49/TERT protein, human; EC 2.7.7.49/Telomerase |
| Comments/Corrections | |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Genistein depletes telomerase activity through cross-talk between genetic and epigenetic mechanisms.
Next Document: Family history of colorectal cancer: a determinant of advanced adenoma stage or adenoma multiplicity...